A. Rapisarda

Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.

I. Steffensen, M. Moreno-Torres, Guillermo Quintás, 2024, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways

J. Pérez-Rojas, Guillem Garcia-Llorens, Iván Rienda, 2024, International journal of molecular sciences.

A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: a case study on chemical-induced liver steatosis.

R. Rodrigues, J. Boeckmans, M. Teunis, 2024, Toxicology.